Furthermore, given the known role of AT inflammation in instigating metabolic and cardiovascular complications [2, 3], we also hypothesized that deletion of Nlrp3 would alleviate Western diet-induced glucose intolerance, arterial stiffening, and cardiac hypertrophy and fibrosis. Here, NLRP3 is linked to Glucose intolerance.